APhA obtains loan to upgrade its office
APhA has obtained a loan to fund the renovation of its existing building and construction of a new adjacent headquarters. The $112 million deal involves a three-year construction and 10-year permanent loan with Hypo Real Estate Capital Corp. The rate is 125 basis points over LIBOR for half of the construction loan and the other half is a fixed rate of 6.16%. The loan then converts to a permanent one with a rate of 6.23%. The association expects the makeover to be completed by 2009.
To see more Hot off the Press news articles, click here.
To go to the Drug Topics homepage, click here.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
